ABSTRACT
Some parasite vaccines, developed for use in the veterinary field, are available in the market. Such vaccines usually contain live or attenuated parasites. Aside from these, a few parasite vaccines have also been prepared using recombinant technology. The objective of this review is to provide information about the antiparasitic vaccines available for use in the veterinary field globally.
Keywords: Parasite, vaccine, veterinary medicine
References
1
Eckert J, Friedhoff KT, Zahner H, Deplazes P. Lehrbuch der parasitologie. 2th auflage. Stuttgard: Enke Verlag; 2008.
2
Wakelin D. Immunity to parasites. How parasitic infections are controlled. 2th ed. United Kingdom: Cambridge Universty Press; 1996.
3
Tizzard IA. Vaccines for veterinarians. St Louis Missouri: Elsevier; 2021.
4
Day MJ, Schultz RD. Veterinary immunology principles and practice. London: Manson Publishing; 2011.
5
Diker KS. İmmunoloji. 1.Baskı. Ankara: Medisan Yayınevi; 1998.
6
Thomaz-Soccol V, Pandey A, Resende RR. Current developments in biotechnology and bioengineering: Human and animal health applications. Amsterdam: Elsevier; 2017.
7
Bowman DD. Georgis parasitology for veterinarians. 10 th ed. St Louis, Missouri: Elsevier Saunders; 2014.
8
World Organisation in Animal Healts. (https://www.oie.int/fileadmin/Home/eng /Health_standards /tahm/3.04.14_THEILIERIOSIS.pdf, Erişim: 14.12.2020)
9
Morrison WI, McKeever DJ. Current status of vaccine development against Theileria parasites. Parasitology 2006; (Suppl133): S169-87.
10
Erganiş O. Hayvansal aşıların geliştirilmesinde üniversite-kamu-sanayi işbirliğinin rolü. Eurasian J Vet Sci 2010; 26: 1-6.
11
Vetal. (https://vetal.com.tr/teylovac, Erişim: 20.12.2020).
12
Dollvet. (https://dollvet.com.tr/asilar/tayledoll, Erişim: 20.12.2020).
13
Aysul N, Karagenç T, Eren H, Aypak S, Bakırcı S. Aydın İli sığırlarında tropikal theileriosisin yaygınlığı ve Theileria annulata şizont aşısının sahada etkinliğinin değerlendirilmesi. Türkiye Parazitol Derg 2008; 32: 322-7.
14
Dubey JP. Coccidiosis in livestock, poultry, companion animals, and humans. Boca Raton London: CRC Press; 2020.
15
Williams RB. Fifty years of anticoccidial vaccines for poultry (1952-2002). Avian dis 2002; 46: 775-802.
16
Drugs.com. (https://www.drugs.com/vet/coccivac-d.html, Erişim: 15.11.2020).
17
Drugs.com (https://www.drugs.com/vet/advent-coccidiosis-vaccine.html, Erişim: 16.11.2020).
18
AgriHealth(https://agrihealth.co.nz/uploads/1e73b0f6b1071 c8c2dccf022833b9877.pdf, Erişim: 25.11.2020).
19
Pugatsch T, Mencher D, Wallach M. Eimeria maxima: isolation of gametocytes and their immunogenicity in mice, rabbits, and chickens. Exp Parasitol 1989; 68: 127-34.
20
Wallach MG, Mencher D, Yarus S, Pillemer G, Halabi A, Pugatsch T. Eimeria maxima: identification of gametocyte protein antigens. Exp Parasitol 1989; 68: 49-56.
21
Wallach M, Halabi A, Pillemer G, Sar-Shalom O, Mencher D, Gilad M, et al. Maternal immunization with gametocyte antigens as a means of providing protective immunity against Eimeria maxima in chickens. Infect Immun 1992; 60: 2036-9.
22
Sharma N, Singh V, Shyma KP. Role of parasitic vaccines in integrated control of parasitic diseases in livestock. Vet World 2015; 8: 590-8.
23
Dantas-Torres F. Leishmune vaccine: the newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission-blocking vaccine. Vet Parasitol 2006; 141: 1-8.
24
Palatnik-de-Sousa CB, Dutra HS, Borojevic R. Leishmania donovani surface glycoconjugate GP36 is the major immunogen component of the fucose-mannose ligand (FML). Acta Trop 1993; 53: 59-72.
25
LeishVet. (http://www.leishvet.org/fact-sheet/vaccines/, Erişim: 27.12.2020).
26
Velez R, Gállego M. Commercially approved vaccines for canine leishmaniosis: a review of available data on their safety and efficacy. Trop Med Int Health 2020; 25: 540-57.
27
Grimaldi G, Teva A, Dos-Santos CB, Santos FN, Pinto ID, et al. Field trial of efficacy of the Leish-tec® vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates. PLoS One 2017; 12: e0185438.
28
Ceva Brasil (https://www.ceva.com.br/Produtos/Lista-de-Produtos/LEISH-TEC, Erişim: 08.01.2021).
29
European Medicines Agency. (https://www.ema.europa.eu/en/medicines/veterinary/EPAR/ canileish, Erişim: 06.01.2021).
30
Virbac. (https://www.virbac.ch/de/kleintiere-produkte/impfstoffe/canileish, Erişim:20.12.2020).
31
NOAH. (http://www.noahcompendium.co.uk/?id=-469126, Erişim: 06.01.2021).
32
European Medicines Agency. (https://www.ema.europa.eu/en/documents/overview/ letifend-epar-summary-public_en.pdf, Erişim: 06.01.2021).
33
Quesland Government Department of Agriculture and Fishes. (https://www.daf.qld.gov.au/__data/assets/pdf_file/0008/61388/Tick-Fever-A2-Trivalent-Tick-Fever-Vaccine-Specifications.pdf, Erişim: 22.10.2020).
34
Business&Personal Solutions Group (http://bpsgroup.net.au/tick-fever-vaccine.html, Erişim: 14.10.2020).
35
CliniPharm/CliniTox. (https://www.vetpharm.uzh.ch/TAK/00000000/ 00001171.VAK, Erişim: 09.02.2021).
36
Le Point Veterinaire.(https://www.lepointveterinaire.fr/dmv/consulter/A1366-/pirodog.html, Erişim: 22.12.2020).
37
European Medicines Agency. (https://www.ema.europa.eu/en/documents/overview/nobivac-piro-epar-summary-public_en.pdf, Erişim: 30.11.2020).
38
Buxton D. Toxoplasmosis: the first commercial vaccine. Parasitol Today 1993; 9: 335-7.
39
Buxton D, Thomson KM, Maley S, Wright S, Bos HJ. Experimental challenge of sheep 18 months after vaccination with a live (S48) Toxoplasma gondii vaccine. Vet Rec 1993; 133: 310-2.
40
NOAH. (http://www.noahcompendium.co.uk/?id=-456186, Erişim: 19.01.2021).
41
MSD Animal Health. (https://www.msd-animal-health.co.nz/products/Toxovax/030_Product_Details.aspx, Erişim: 05.01.2021).
42
Drugs.com (https://www.drugs.com/vet/trichguard.html, Erişim: 19.01.2021).
43
Drugs.com (https://www.drugs.com/vet/trichguard-v5l.html, Erişim: 19.01.2021).
44
BonDurant RH. Pathogenesis, diagnosis, and management of trichomoniasis in cattle. Vet Clin North Am Food Anim Pract 1997; 13: 345-61.
45
MSD Animal Health. (https://www.msd-animal-health.ie/Binaries/Huskvac_Tech_Bulletin_tcm102-94084.pdf, Erişim:25.10.2020).
46
Claerebout E, Geldhof P. Helminth Vaccines in Ruminants: From Development to Application. Vet Clin North Am Food Anim Pract 2020; 36: 159-71.
47
LeJambre LF, Windon RG, Smith WD. Vaccination against Haemonchus contortus: performance of native parasite gut membrane glycoproteins in Merino lambs grazing contaminated pasture. Vet Parasitol 2008; 153: 302-12.
48
Veterinary Vaccinology Networks. (https://www.vetvaccnet.ac.uk/sites/vetnet/files/user-files/research-paper/pdf/02-15/Barbevax-%20Haemonchus%20vaccine.pdf, Erişim: 06.11.2020).
49
World Health Organisation. (https://www.who.int/news-room/fact-sheets/detail/echinococcosis, Erişim: 17.01.2021).
50
Techovax. (http://www.tecnovax.com.ar/wpcontent/uploads/2015/08/ BrochureHidatidosisWeb.pdf, Erişim: 15.01.2021).
51
Zhang ZZ, Guo G, Li J, Shi BX, Zhao L, Guo BP, et al. Dog vaccination with EgM proteins against Echinococcus granulosus. Infect Dis Poverty 2018; 7: 61.
52
CPhI Online. (https://www.cphi-online.com/cysvax-prod1235247.html, Erişim: 11.11.2020).
53
Swine Health&Cysticercosis. (https://cysticercosis.in/cysticercosis? page=pig-vaccination Erişim:02.02.2021).
54
Suarez M, Rubi J, Perez D, Cordova V, Salazar Y, Vielma A, et al. High impact and effectiveness of Gavac™ vaccine in the national program for control of bovine ticks Rhipicephalus microplus in Venezuela. Livest Sci 2016; 187: 48-52.
55
Tecnovax. (http://www.aquatecsealice.com, Erişim: 24.01.2021).
56
Price DRG, Küster T, Øines Ø, Oliver EM, Bartley K, Nunn F, et al. Evaluation of vaccine delivery systems for inducing long-lived antibody responses to Dermanyssus gallinae antigen in laying hens. Avian Pathol 2019; 48(sup1): S60-S74.
57
Bartley K, Wright HW, Huntley JF, Manson ED, Inglis NF, McLean K, et al. Identification and evaluation of vaccine candidate antigens from the poultry red mite (Dermanyssus gallinae). Int J Parasitol 2015; 45: 819-30.
58
Horcajo P, Regidor-Cerrillo J, Aguado-Martínez A, Hemphill A, Ortega-Mora LM. Vaccines for bovine neosporosis: current status and key aspects for development. Parasite Immunol 2016; 38: 709-23.
